keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 2 - Wednesday 9th October - CET (Central European Time, GMT+01:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Day 2 - Wednesday 9th October - CET (Central European Time, GMT+01:00)
search
Streams
Formats
Showing 2 of 2 Streams
BIOTECH LEADERS
MEDTECH & HEALTHTECH LEADERS
09:00 - 09:10
LSX WELCOME
- Adam Griffiths - Portfolio Manager, LSX Leaders
09:10 - 09:50
Keen to Go Green: Sustainability in Nordic Life Sciences
- Mette Wendel - Senior Project Manager, Kalundborg Symbiosis
- Daniel Eriksson - Founder & CEO, Nordic Center for Sustainable Healthcare
- Dorethe Nielsen - VP, Circular for Zero Corporate Environmental Strategy, Novo Nordisk
09:50 - 10:30
Gender Equality in Health? Nordic Perspectives on Women's Health
- Anette Steenberg - CEO, Medicon Valley Alliance
- Darine Ghanem - General Manager, Roche Denmark
- Ina Laura Perkins - CEO, Scandinavian Real Hearts
09:00 - 09:10
LSX Welcome
09:10 - 09:50
Driving Investment in Digital Health and Medical Devices in the Nordic Region
- The Nordic region is one of the most dynamic and innovative in the world – do they investment trends correlate with this?
- Understanding the barriers and opportunities to increase investments in Nordic innovation
- Improving the exit landscape in Nordic healthtech and medtech
- How is the convergence of VC and PE in healthtech & medtech is reshaping the investment and startup landscape?
09:50 - 10:30
Innovate, Scale, Profit - Crafting Your Device or Digital Health Commercial Strategy and Business Model
- When to start thinking about commercialisation
- The stakeholders you need, and when to engage them
- It’s not biotech! The realities of growing your digital health and device company
Showing 1 of 1 Streams
Break
10:30 - 11:00
Morning Break
Showing 2 of 2 Streams
BIOTECH LEADERS
MEDTECH & HEALTHTECH LEADERS
11:00 - 11:50
Nordic Biotech Brilliance: Unleashing the Talent Magnet for Sustained and Retained Innovation
- Reagan Jarvis - CEO & Co-founder, Anocca, Sweden
- Georgina Askeland - Senior Investment Associate, Hadean Ventures
- Ulrika Warpman Berglund - CEO, Oxcia
- Agnete Fredriksen - Co-founder & CBO, Nykode Therapeutics
11:50 - 12:40
Go West, but is it Best? Unravelling the Nordic and US IPO Markets
- Ulrica Slåne Bjerke - Founder & CIO, Arctic Aurora LifeScience
- Lene Gerlach - Partner, Eir Ventures
- Vanessa Carle - Partner, Forbion
11:00 - 11:40
Leveraging Nordic Strengths - Remote Patient Monitoring & Redefining the Standard-of-Care
- Striving towards digitising healthcare services for citizens in the Nordic region
- Looking across the region, how can we increase slow adoption of RPMs in some countries?
- What is required to ensure successful remote monitoring implementations at scale?
- Using AI to optimise remote patient monitoring
11:40 - 12:20
Achieving Patient Centricity, Scale & Profitability With Digital Therapeutics
- Which digital therapeutics business models are working in the real world? What is the business model of the future?
- Given the issues with reimbursement, what are companies doing to survive?
- Evaluating the effectiveness of DTx partnerships with Pharma
- Addressing investor hesitancy and raising funds
Showing 1 of 1 Streams
Break
12:40 - 14:00
Lunch Break
Showing 2 of 2 Streams
BIOTECH LEADERS
MEDTECH & HEALTHTECH LEADERS
14:00 - 14:50
Arming Against Antimicrobial Resistance: Nordic Strategies in the AMR Battlefield
- Stine Hasling Mogensen - Chair, Pharmadanmark
- Hans Jørn Kolmos - Professor, University of Southern Denmark
- Steffen Pierini Lüders - SVP, Corporate Affairs, Novo Nordisk Foundation
14:50 - 15:40
ATMPs and a New Paradigm Shift for Patients: Initiatives and Ambitions in the Nordics
- Agnete Kirkeby - Associate Professor, University of Copenhagen and Lund University
- Anna Falk - Director, LU-ATMP
- David Morrow - Senior Scientific Program Manager and Platform Coordinator, EATRIS
14:00 - 14:50
Strategies for A Successful Medtech & Healthtech Exit
The exit is clear, but the path to the door is littered with a myriad of challenges and pitfalls. Medtech and healthtech companies who have deciphered their path through the maze early in their commercial story will prove value to investors and future partners. This panel provides the opportunity for companies to determine their exit roadmap.
- Nordic exit pathways – what's out there?
- Strategies for international IPOs and mergers
- Finding your champions
14:50 - 15:40
Data, Devices and Digital – The 2030 Personalised Treatment Pathway
The Nordic Health 2030 Movement aims to improve health at both individual and societal levels by shifting focus from sick care to preventive measures. This panel explores how the region is currently tracking in achieving this goal, and how far it is yet to go.
- Roadblocks to inter-regional connectivity
- Innovations that are leading the way and what's missing?
- What regional support is available for companies tackling this issue?
Showing 1 of 1 Streams
Break
15:40 - 15:45
Close of Congress
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Formats